Finance

Lists
Why is TELA down 4.64%?
Dive Deeper
TELA:NASDAQ
TELA Bio Inc
$0.82
-4.64%
(-0.040) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TELA...
Open
$0.82
High
$0.84
Low
$0.76
Mkt. cap
37.06M
Avg. vol.
150.87K
Volume
129.18K
52-wk high
$1.50
52-wk low
$0.50
EPS
-$0.77
Beta
1.46
Shares outstanding
45.19M
No. of employees
218
Open
$0.82
High
$0.84
Low
$0.76
Mkt. cap
37.06M
Avg. vol.
150.87K
Volume
129.18K
52-wk high
$1.50
52-wk low
$0.50
EPS
-$0.77
Beta
1.46
Shares outstanding
45.19M
No. of employees
218
News stories
From web sources and news partners
About TELA Bio Inc
CEO-
Employees218
Founded2012
HeadquartersMalvern, Pennsylvania, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 4 analysts giving stock ratings to TELA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TELA in the last 3 months.
Highest
Current $0.82
$2.00 (+143.87%)
Average
$1.75 (+113.39%)
Lowest
$1.00 (+21.94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$2.00
+143.9%
11/11/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$1.00
+21.9%
11/11/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$2.00
+143.9%
09/30/2026
Chase Knickerbocker
Craig-Hallum
Buy
Initiated
$2.00
+143.9%
09/25/2026
David Turkaly
Citizens JMP
Buy
Maintained
$3.00
+265.8%
03/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
20.87M
19.06M
19.29M
18.96M
Cost of goods sold
7.02M
6.44M
5.25M
6.56M
Cost of revenue
7.02M
6.44M
5.25M
6.56M
Research and development expenses
2.13M
2.34M
2.72M
1.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.27M
20.70M
20.50M
16.01M
Operating expense
20.50M
23.14M
23.32M
19.69M
Total operating expenses
27.52M
29.58M
28.57M
26.25M
Operating income
-6.65M
-10.53M
-9.28M
-7.29M
Other non operating income
277.00K
366.00K
157.00K
190.00K
EBT including unusual items
-8.90M
-12.21M
-11.20M
-9.20M
EBT excluding unusual items
-8.01M
-12.21M
-11.20M
-9.20M
Income tax expense
145.00K
60.00K
60.00K
103.00K
Effective tax rate
-1.63%
-0.49%
-0.54%
-1.12%
Other operating expenses
-
-
-
1.98M
Net income
-9.04M
-12.27M
-11.26M
-9.30M
Net profit margin
-43.32%
-64.39%
-58.38%
-49.06%
Earnings per share
-0.17
-0.21
-0.20
-0.16
Interest and investment income
-
-
-
-
Interest expense
-1.64M
-2.05M
-2.08M
-2.10M
Net interest expenses
-1.64M
-2.05M
-2.08M
-2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.42M
-10.26M
-9.02M
-7.02M
Gain or loss from assets sale
-
18.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps